Odén A - Search Results

1

The cost-effectiveness of treating hypertension in elderly people--an analysis of the Swedish Trial in Old Patients with Hypertension (STOP Hypertension).

Johannesson M, Dahlöf B, Lindholm LH, Ekbom T, Hansson L, Odén A, Scherstén B, Wester PO, Jönsson B. Johannesson M, et al. Among authors: oden a. J Intern Med. 1993 Sep;234(3):317-23. doi: 10.1111/j.1365-2796.1993.tb00749.x. J Intern Med. 1993. PMID: 8354983 Clinical Trial.

2

The stroke preventive effect in elderly hypertensives cannot fully be explained by the reduction in office blood pressure--insights from the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension).

Ekbom T, Dahlöf B, Hansson L, Lindholm LH, Odén A, Scherstén B, Wester PO. Ekbom T, et al. Among authors: oden a. Blood Press. 1992 Oct;1(3):168-72. doi: 10.3109/08037059209077513. Blood Press. 1992. PMID: 1345050 Clinical Trial.

3

Blood pressure does not predict mortality in the elderly.

Ekbom T, Lindholm L, Odén A, Dahlöf B, Hansson L, Scherstén B, Wester PO. Ekbom T, et al. Among authors: oden a. J Hypertens Suppl. 1988 Dec;6(4):S626-8. doi: 10.1097/00004872-198812040-00196. J Hypertens Suppl. 1988. PMID: 3241270

4

A 5-year prospective, observational study of the withdrawal of antihypertensive treatment in elderly people.

Ekbom T, Lindholm LH, Odén A, Dahlöf B, Hansson L, Wester PO, Scherstén B. Ekbom T, et al. Among authors: oden a. J Intern Med. 1994 Jun;235(6):581-8. doi: 10.1111/j.1365-2796.1994.tb01265.x. J Intern Med. 1994. PMID: 8207364 Clinical Trial.

5

Cost effectiveness of raloxifene in the treatment of osteoporosis in Sweden: an economic evaluation based on the MORE study.

Borgström F, Johnell O, Kanis JA, Oden A, Sykes D, Jönsson B. Borgström F, et al. Among authors: oden a. Pharmacoeconomics. 2004;22(17):1153-65. doi: 10.2165/00019053-200422170-00005. Pharmacoeconomics. 2004. PMID: 15612833

6

Effect and offset of effect of treatments for hip fracture on health outcomes.

Jonsson B, Kanis J, Dawson A, Oden A, Johnell O. Jonsson B, et al. Among authors: oden a. Osteoporos Int. 1999;10(3):193-9. doi: 10.1007/s001980050215. Osteoporos Int. 1999. PMID: 10525710

7

Cost-effectiveness of preventing hip fracture in the general female population.

Kanis JA, Dawson A, Oden A, Johnell O, de Laet C, Jonsson B. Kanis JA, et al. Among authors: oden a. Osteoporos Int. 2001;12(5):356-61. doi: 10.1007/s001980170102. Osteoporos Int. 2001. PMID: 11444082

8

Cost-effectiveness of raloxifene in the UK: an economic evaluation based on the MORE study.

Kanis JA, Borgström F, Johnell O, Oden A, Sykes D, Jönsson B. Kanis JA, et al. Among authors: oden a. Osteoporos Int. 2005 Jan;16(1):15-25. doi: 10.1007/s00198-004-1688-0. Epub 2004 Jul 24. Osteoporos Int. 2005. PMID: 15672210 Clinical Trial.

9

Intervention thresholds for osteoporosis.

Kanis JA, Johnell O, Oden A, De Laet C, Oglesby A, Jönsson B. Kanis JA, et al. Among authors: oden a. Bone. 2002 Jul;31(1):26-31. doi: 10.1016/s8756-3282(02)00813-x. Bone. 2002. PMID: 12110408

10

The burden of hospitalised fractures in Sweden.

Johnell O, Kanis JA, Jonsson B, Oden A, Johansson H, De Laet C. Johnell O, et al. Among authors: oden a. Osteoporos Int. 2005 Feb;16(2):222-8. doi: 10.1007/s00198-004-1686-2. Epub 2004 Jul 1. Osteoporos Int. 2005. PMID: 15232678

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

369 results

Search Page